Medtronic (NYSE:MDT) said today that it’s launching a new sinus surgery device, NovaShield, for functional endoscopic sinus surgery.
The NovaShield device consists of a chitosan-based injectable nasal packing and a stent, according to a press release. The FDA granted 510(k) clearance for the device in October, Medtronic said.
Sign up to get our free ne
"NovaShield is Medtronic’s first chitosan-based nasal packing," ENT biomaterials product manager Lisa Sapp said in prepared remarks. "With the benefits of chitosan and its unique design, NovaShield is helpful for both surgeons and patients."
"Nasal packing is an important factor in postoperative care and the ultimate outcome of sinus surgery," added ENT business general manager Vince Racano. "We’re excited to bring sinus surgeons this convenient new tool for FESS."